RESUMEN
BACKGROUND: Neuromyelitis Optica Spectrum Disorder (NMOSD) is an inflammatory autoimmune disease with high risk of recurrence and disability, the treatment goal is a recurrence free state. Area postrema (AP) is one of the most common involved area of NMOSD, which may have a particular significance in the pathogenesis of NMOSD and clinical heterogeneity. Our study is to investigate the clinical and recurrent characteristics AP onset NMOSD patients. METHODS: A retrospective study was done in a cohort of 166 AQP4-IgG seropositive NMOSD patients which were identified by the 2015 IPND criteria. The patients were divided into AP onset (APO-NMOSD) group and non-AP onset (NAPO-NMOSD) group based on the initial episode location. Clinical features and recurrence differences of two groups were compared. RESULTS: The APO-NMOSD group and NAPO-NMOSD group had a population ratio of 24:142. APO-NMOSD patients were younger (34.6y VS 42.3y, P = 0.013), had lower EDSS at first episode (0.7 VS 4.2, p = 0.028) and last follow up (1.9 VS 3.3, p = 0.001), more likely to have multi-core lesions at the first attack (33.3% VS 9.2%, P = 0.001). Also, they had a higher annual recurrence rate (0.4 ± 0.28 VS 0.19 ± 0.25, P = 0.012). In natural course NMOSD patients without immunotherapy, APO-NMSOD had a shorter time of first relapse (P < 0.001) and higher annual recurrence rate (0.31 ± 0.22 VS 0.16 ± 0.26, P = 0.038) than NAPO-NMOSD. APO-NMOSD group also have a higher risk of having the first relapsing compared to optic neuritis onset-NMOSD (HR 2.641, 95% CI 1.427-4.887, p = 0.002) and myelitis onset-NMOSD group (HR 3.593, 95% CI 1.736-7.438, p = 0.001). Compared to NAPO-NMOSD, APO-NMOSD has a higher likelihood of brainstem recurrence (28.6% vs. 4.7%, p<0.001) during the first recurrence, while NAPO-NMOSD is more susceptible to optic nerve involvement (10.7% vs. 41.1%, p = 0.01). CONCLUSION: AQP4-IgG seropositive NMOSD patients with AP onset are youngers and have higher risk of recurrence. Clinicians should pay attention to AP damage in NMOSD, as it indicates a potential risk of recurrence. TRIAL REGISTRATION: Retrospectively registered.
Asunto(s)
Área Postrema , Neuromielitis Óptica , Recurrencia , Humanos , Neuromielitis Óptica/epidemiología , Neuromielitis Óptica/diagnóstico , Femenino , Estudios Retrospectivos , Adulto , Masculino , Persona de Mediana Edad , Área Postrema/patología , Adulto Joven , Estudios de Cohortes , Acuaporina 4/inmunologíaRESUMEN
Neuromyelitis optica (NMO) is a disease distinct from multiple sclerosis in terms of clinical and magnetic resonance imaging (MRI) manifestations. Antibody to aquaporin-4 (AQP4) has been identified as a specific biomarker and part of the diagnostic criteria for NMO. Although it is relatively common in Asia, a comprehensive clinical and imaging evaluation of NMO has not been reported in Chinese patients. Here, we reviewed data from 57 Chinese cases. The patients had an obvious female preponderance (female/male = 8.5:1), and transverse myelitis (82.5%) and optic neuritis (56.1%) were the most common manifestations. In MRI, longitudinally extensive transverse myelitis (6.9 ± 2.3 segments) dominated the spinal cord lesions, which were mainly (69.7%) distributed in cervical and thoracic cord. However, the length of the lesions was not correlated with onset age, paralysis severity, relapse rate, or duration. Among 29 patients who underwent AQP4 antibody assay, 17 (58.6%) were positive. There was no difference between seropositive and seronegative patients in terms of female preponderance, onset age, relapse rate, and Expanded Disability Status Scale score. However, seropositive patients had significantly more damaged segments (8.3 ± 3.5) than did seronegative patients (4.5 ± 1.6) (p < 0.001). The data revealed the clinical and MRI characteristics and AQP4 antibody status of NMO in Chinese patients and the correlations between them, which may have important implications for the diagnosis of the disease.
Asunto(s)
Neuromielitis Óptica/patología , Médula Espinal/patología , Adulto , Acuaporina 4/inmunología , Pueblo Asiatico , Autoanticuerpos/sangre , China , Femenino , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Mielitis Transversa/sangre , Mielitis Transversa/líquido cefalorraquídeo , Mielitis Transversa/patología , Neuromielitis Óptica/sangre , Neuromielitis Óptica/líquido cefalorraquídeo , Trastornos de la Visión/sangre , Trastornos de la Visión/líquido cefalorraquídeo , Trastornos de la Visión/patología , Adulto JovenRESUMEN
BACKGROUND: Patients with mild cognitive impairment (MCI) suffer from a high risk of developing Alzheimer's disease (AD). Cumulative evidence has demonstrated that the development of AD is a complex process that could be modulated by miRNAs. Here, we aimed to identify miRNAs involved in the pathway, and interrogate their ability to predict prognosis in patients with MCI. METHODS: We obtained the miRNA-seq profiles and the clinical characteristics of patients with MCI from the Gene Expression Omnibus (GEO). Cox regression analysis was used to construct a risk level model. The receiver operating characteristic (ROC) curve was used to assess the performance of the model for predicting prognosis. Combined with clinical characteristics, factors associated with prognosis were identified and a predictive prognosis nomogram was developed and validated. Through Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis, we evaluated molecular signatures for the candidate miRNAs. RESULTS: Our analysis identified 120 DEmiRNAs. The Cox regression analysis showed that two miRNAs could serve as risk factors for disease development. A risk level model was constructed. Age, apoe4, and risk level were associated with the prognosis. We developed a nomogram to predict disease progression. The calibration curve and concordance index (C-index) demonstrated the reliability of the nomogram. Functional enrichment analysis showed that these miRNAs were involved in regulating both cGMP-PKG and Sphingolipid signaling pathways. CONCLUSION: We have identified miRNAs associated with the development of MCI. These miRNAs could be used for early diagnosis and surveillance in patients with MCI, enabling prediction of the development of AD.
Asunto(s)
Enfermedad de Alzheimer , MicroARNs , Enfermedad de Alzheimer/diagnóstico , Enfermedad de Alzheimer/genética , Apolipoproteína E4 , Humanos , MicroARNs/genética , MicroARNs/metabolismo , Reproducibilidad de los Resultados , EsfingolípidosRESUMEN
At present, the effect characteristics and mechanism of organic fertilizer replacing chemical fertilizer on organic carbon mineralization and active organic carbon in dryland yellow soil remain unclear. In order to explore the effect of organic fertilizer replacing chemical fertilizer on organic carbon mineralization and active organic carbon in dryland yellow soil, we used soil with no fertilization (CK), only chemical fertilizer (NP), 50% organic fertilizer replacing chemical fertilizer (1/2(NPM)), and 100% organic fertilizer replacing chemical fertilizer (M). We examined the indoor mineralization culture of organic carbon and explored the characteristics of soil organic carbon and the change in active organic carbon under the condition of organic fertilizer replacing chemical fertilizer. The results showed that organic fertilizer replacing chemical fertilizer increased soil pH, organic carbon (SOC), total nitrogen (TN), and C/N. During the culture period, the soil organic carbon mineralization rate of all treatments decreased sharply in the initial stage (2-4 days), decreased slightly in the middle stage (4-20 days), and tended to be stable in the last stage (20-60 days). After fertilization, the cumulative mineralization of soil organic carbon significantly increased by 7.9%-27.7%. Compared with that in the NP treatment, the cumulative mineralization of soil organic carbon decreased by 5.2% in the 1/2(NPM) treatment and increased by 12.2% in the 1/2(NPM) treatment. Before mineralization culture, the substitution of organic fertilizer for chemical fertilizer had no significant effect on soil recalcitrant organic carbon (ROC) but significantly increased the content of microbial biomass carbon (MBC). The content of dissolved organic carbon (DOC) was significantly increased in the 1/2(NPM) treatment and decreased in the M treatment. After 60 days of culture, the content of soil active organic carbon in all treatments decreased compared with the initial content, of which MBC decreased the most (30.6%-41.2%). The accumulated mineralization of organic carbon was significantly positively correlated with soil pH and SOC and significantly positively correlated with the initial value of MBC and the change value before and after culture. To summarize, 100% organic fertilizer replacing chemical fertilizer significantly promoted soil organic carbon mineralization and reduced soil organic carbon stability; 50% organic fertilizer replacing chemical fertilizer inhibited soil organic carbon mineralization, which was beneficial to soil sequestration and fertilization; and 50% organic fertilizer replacing chemical fertilizer significantly increased soil active organic carbon content, and MBC was used as the main carbon source in the process of soil organic carbon mineralization.
Asunto(s)
Fertilizantes , Suelo , Agricultura/métodos , Carbono/química , Carbón Orgánico , Nitrógeno , Suelo/químicaRESUMEN
Background: Neuronal intranuclear inclusion disease (NIID) is a rare neurodegenerative disease. The clinical manifestations of NIID are complex and easily misdiagnosed. Based on the current knowledge of this disease, it is usually chronic, with almost no acute cases. Stroke-like disease is an extremely rare type of NIID. Case Presentation: A 61-year-old woman was admitted to our hospital with sudden left limb weakness. Diffusion magnetic resonance imaging (MRI) demonstrated high signal intensity in the skin-medullary junction area. Tissue pathology showed eosinophilic inclusions in the nuclei of the sweat gland cells and fat cells of the skin. Subsequent genetic analysis of the fragile X chromosome mental retardation gene 1 (FMR1) gene showed that the CGG repeat number was in the normal range, excluding fragile X-related tremor/ataxia syndrome (FXTAS). After 3 weeks of hospitalization, the patient's condition improved, and the left limb muscle strength recovered. Her symptoms were almost completely diminished after 3 months. Conclusion: This case demonstrates the strong clinical heterogeneity of NIID. NIID can manifest as acute hemiplegia and a stroke-like attack. This case study provides new information for the diagnosis of NIID and the classification of the clinical characteristics.
RESUMEN
In multiple sclerosis, gray matter atrophy is extensive, and cognitive deficits and mood disorders are frequently encountered. It has been conjectured that focal atrophy is associated with emotional decline. However, conventional MRI has revealed that the pathological characteristics cannot fully account for the mood disorders. Moreover, there is no correlation between cognitive disorders and MRI results in clinically isolated syndromes or in cases of definite multiple sclerosis. In this case-control study, voxel-based morphometric analysis was performed on 11 subjects with relapsing-remitting multiple sclerosis, and the results show that these patients exhibit gray matter atrophy. Moreover, the gray matter atrophy in the superior and middle gyri of the right frontal lobe in patients with multiple sclerosis was correlated with scores from the Hamilton Anxiety Rating Scale. The scores obtained with the Repeatable Battery for the Assessment of Neuropsychological Status were associated with gray matter atrophy in the middle gyrus of the left frontal lobe, the superior and middle gyrus of the right frontal lobe, the middle gyrus of the left cingulate, the superior and middle gyri of the left frontal lobe, and the triangular area of the left frontal lobe. However, there was no statistical significance. These findings suggest that the cingulate and frontal cortices of the nant hemisphere are the most severely atrophic regions of the brain, and this atrophy is correlated with cognitive decline and emotional abnormalities.